BioCatalyst

BI 764524, Aflibercept (Eylea®) - US only — catalyst calendar

1 verified catalyst event(s) referencing BI 764524, Aflibercept (Eylea®) - US only, each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-05
in 4mo
ESTIMATED
 READOUT
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab
Phase 2 · Diabetic Retinopathy
 Boehringer Ingelheim BI 764524, Aflibercept (Eylea®) - US onl ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.